About Molecular Innovations
Molecular Innovations is a Healthcare company based in Detroit (United States) founded in 1990, and was acquired by Innovative Research in October 2021. Bioreagents for coagulation and thrombolysis research are manufactured and marketed. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Reagents and Kits and Proteomics.
Company details
Founded in 1990 and based in Detroit, United States, Molecular Innovations operates in the biotechnology sector. A wide range of bioreagents, including PAI-1, tPA, urokinase, clotting factors, vitronectin, fibrinogen, fibronectin, proreninrenin, albumin, monoclonal and polyclonal antibodies, chromatography resins, and ELISA kits, is produced for research and clinical laboratories. Custom projects are provided to pharmaceutical, biotechnology companies, and research institutions worldwide.
- Headquarters Detroit, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website mol-innov.com
- Social LinkedIn X Facebook YouTube
- Acquired by Innovative Research (Oct 2021)
- Investors
- Acquired byInnovative Research
(Oct 2021)
Apps and channels of Molecular Innovations
its YouTube channel Innovative Research has 2.31K subscribers.
Investors in Molecular Innovations
Molecular Innovations has secured backing from 1 investor. Prominent investors backing the company include Innovative Research.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Innovative Research is engaged in providing biomaterials and research tools. | innov-research.com | Novi, United States |
Investor details for Molecular Innovations
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Molecular Innovations
2 dated milestones of Molecular Innovations across 31 years, from founding to its latest funding, stage changes and deals.
- Founded Molecular Innovations is founded.
- Exit Acquired by Innovative Research.
Web traffic of Molecular Innovations
Websites that share an audience with Molecular Innovations (mol-innov.com).
Websites whose visitors overlap most with Molecular Innovations. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| oxfordbiomed.com | 100% | 3.8K | #4,977,915 | View details | |
anogen.ca | anogen.ca | 100% | – | ||
| bioassaysys.com | 100% | 12.4K | #2,032,630 | View details | |
| mitosciences.com | 92% | View details | |||
uscnlife.com | uscnlife.com | 90% | – | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 15 similar websites and full traffic analytics for Molecular Innovations
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 15 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Molecular Innovations (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Molecular Innovations
Complete news archive for Molecular Innovations
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Molecular Innovations
Molecular Innovations was founded in 1990.
Molecular Innovations is headquartered in Detroit, United States. It is registered at Detroit, Michigan, United States.
Founded in 1990 and based in Detroit, United States, Molecular Innovations operates in the biotechnology sector. A wide range of bioreagents, including PAI-1, tPA, urokinase, clotting factors, vitronectin, fibrinogen, fibronectin, proreninrenin, albumin, monoclonal and polyclonal antibodies, chromatography resins, and ELISA kits, is produced for research and clinical laboratories. Custom projects are provided to pharmaceutical, biotechnology companies, and research institutions worldwide.
Molecular Innovations has 1 investor. Key investors include Innovative Research.
Yes. Molecular Innovations was acquired by Innovative Research in October 2021.